CardioDx strikes deal to bring artery disease assay to India

04/26/2013 | GenomeWeb Daily News (free registration)

CardioDx has agreed to allow Core Diagnostics India to distribute its Corus CAD diagnostic system in India for undisclosed terms. The blood-based gene expression test, which was released as a laboratory-developed assay in 2009, is intended to screen patients showing symptoms of obstructive coronary artery disease.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ